CD133、CD44和巢蛋白表达与高级别脑膜瘤预后因素的关联
该研究纳入51例WHO II/III级脑膜瘤,用免疫组化检测CD133、CD44和巢蛋白表达,分析其与年龄、性别、初始WHO分级、Simpson分级及辅助放疗的关系。中位总生存7.1年,中位无进展生存1.8年。单因素分析显示CD133和巢蛋白表达与PFS负相关,多因素分析显示二者与PFS相关。
要点
- 中位总生存7.1年,中位无进展生存1.8年。
- 单因素分析CD133和巢蛋白表达与PFS负相关(P=0.0176和P=0.0138)。
- 多因素分析显示CD133和巢蛋白表达与PFS相关。
核心结论
- CD133和巢蛋白表达、初始WHO分级和Simpson分级与II/III级脑膜瘤患者的PFS相关。
研究设计与样本
- 对51例II/III级脑膜瘤进行免疫组化检测,评估CD133、CD44和巢蛋白表达与预后的相关性。
主要发现
- 中位总生存7.1年,中位无进展生存1.8年。
- 单因素Cox回归显示CD133表达与PFS负相关(P=0.0176),巢蛋白表达与PFS负相关(P=0.0138)。
- CD44高表达显示PFS缩短的趋势(P=0.0563),初始WHO分级和Simpson分级也显示与PFS相关(P=0.0166和P=0.0333)。
- 多因素分析显示CD133和巢蛋白表达与PFS相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meningioma is the most common primary brain tumor. It is graded as I, II, or III based on the World Health Organization (WHO) classification of central nervous system tumors. Meningiomas, especially those classified as grade II-III, have an aggressive history and a high recurrence rate. Cancer stem cells (CSCs) represent a small subset of tumor cells and are considered to be involved in tumor initiation, growth, and/or recurrence. To date, the CSCs of meningioma have not been well established. METHODS: We assessed 51 grade II/III meningiomas using immunohistochemistry to determine if a correlation exists with the prognosis by investigating CD133, CD44, and nestin expression as possible CSC markers and age, gender, initial WHO tumor grade, Simpson grade, and the use of adjuvant radiation therapy. RESULTS: The median overall survival was 7.1 years, and the median progression-free survival (PFS) was 1.8 years. Univariate analysis using Cox proportional hazards regression revealed a negative correlation between CD133 and nestin expression and PFS (P = 0.0176 and P = 0.0138, respectively), and high expression of CD44 demonstrated a tendency toward a shorter PFS (P = 0.0563), as did the initial WHO grade and Simpson grade found at the initial operation (P = 0.0166 and P 0.0333, respectively). Multivariate analysis showed relevance between CD133 and nestin expression and PFS. CONCLUSIONS: CD133 and nestin expression, initial WHO grade and Simpson grade were associated with PFS in patients with grade II/III meningioma. These findings might suggest that these molecules are representative of CSCs in meningioma regarding the aspect of clinical course.
引用
- Kamamoto D, Saga I, Ohara K, et al. Association Between CD133, CD44, and Nestin Expression and Prognostic Factors in High-Grade Meningioma. World Neurosurg. 2018. PMID: 30593958. doi:10.1016/j.wneu.2018.12.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。